Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Olba DVx HealthcareTSE:2689 +1.95%62 EV-to-EBIT is 6.38 as of Sep. 03, 2026, which is 6% below its 10-year median of 6.80. GuruFocus rates TSE:2689 with a GF Score™ of 62/100 and a GF Value™ of 円2,159.64 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 97 Medical Distribution companies, Olba DVx Healthcare ranks better than 77.32% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Olba DVx Healthcare's Enterprise Value for the quarter that ended in Mar. 2026 was 円13,119 Mil.
Olba DVx Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,835 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Olba DVx Healthcare EV-to-EBIT Related Terms
Olba DVx Healthcare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Olba DVx Healthcare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Olba DVx Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olba DVx Healthcare EV-to-EBIT vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Olba DVx Healthcare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Olba DVx Healthcare's EV-to-EBIT falls into.
Olba DVx Healthcare's current Enterprise Value is 円11,703 Mil.
Olba DVx Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,835 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Olba DVx Healthcare (TSE:2689) has a EV-to-EBIT of 6.38 as of Sep. 03, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Olba DVx Healthcare and its competitors. This is near median its historical median of 6.80. Over the past decade, Olba DVx Healthcare's EV-to-EBIT has ranged from 3.04 to 21.93. According to the industry distribution chart, Olba DVx Healthcare ranks #22 out of 97 companies in the Medical Distribution industry, placing it in the top 22.7%.
Is Olba DVx Healthcare's EV-to-EBIT too high?
Olba DVx Healthcare's current EV-to-EBIT of 6.38 is near median its 10-year median of 6.80. Over the past 10 years, this metric has ranged from a low of 3.04 to a high of 21.93. The Medical Distribution industry median EV-to-EBIT is 11.30. Olba DVx Healthcare's value of 6.38 is 43.5% below this industry median. Based on the distribution chart, Olba DVx Healthcare ranks #22 out of 97 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Olba DVx Healthcare has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olba DVx Healthcare's EV-to-EBIT compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Olba DVx Healthcare ranks #22 out of 97 companies for EV-to-EBIT. This places Olba DVx Healthcare in the top 23% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 11.30. Olba DVx Healthcare's value of 6.38 is 43.5% below this benchmark. Historically, Olba DVx Healthcare's own EV-to-EBIT has ranged from 3.04 to 21.93 over the past decade. While the company's 10-year median is 6.80 vs. the industry median of 11.30, Olba DVx Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 11.30, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Olba DVx Healthcare's current EV-to-EBIT of 6.38 is 43.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Olba DVx Healthcare and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 11.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olba DVx Healthcare's current EV-to-EBIT is 6.38, which is near median its own 10-year median of 6.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba DVx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Olba DVx Healthcare (TSE:2689) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,159.64, compared to a current price of 円1,932.00 — trading 10.5% below its estimated fair value. The current EV-to-EBIT is 6.38, which is near median its 10-year median of 6.80 and 43.5% below the Medical Distribution industry median of 11.30. Olba DVx Healthcare's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Olba DVx Healthcare (TSE:2689), the current EV-to-EBIT is 6.38 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olba DVx Healthcare (TSE:2689) Overvalued in 2026?
Based on GuruFocus' analysis, Olba DVx Healthcare stock appears to be undervalued.
The current stock price of 円1,932.00 is trading 10.5% below its estimated GF Value™ of 円2,159.64.
GuruFocus considers Olba DVx Healthcare to be Modestly Undervalued.
Key valuation signals for TSE:2689:
EV-to-EBIT: 6.38 (near median its 10-year median of 6.80)
GF Value™: 円2,159.64 vs. price of 円1,932.00 (10.5% below fair value)
Industry Position: 43.5% below the Medical Distribution median (#22 of 97)
No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
62GF Score
Get the complete analysis for TSE:2689
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2689 has been successfully added to your 
